PDE5A and Charcot-Marie-Tooth disease type 1B: We previously reported that treating the S63del mouse model of CMT1B with the PDE5 inhibitor sildenafil restored proteostasis and lessened neuropathy [20], presumably by reducing the accumulation of MPZS63del in Schwann cells by enhancing its degradation by 26S proteasomes.